Market Place
Sourcing Support
Clovis Oncology Announces First Patient Enrolled in the Ph2 Portion the LIO-1
04 Aug 2020 //
BUSINESSWIRE
New Preclinical Data on ALKS 4230 in Comb Lucitanib Presented at 2020 (AACR)
22 Jun 2020 //
PRNEWSWIRE
Clovis Oncology to Highlight Rubraca®& Lucitanib Non-Clinical Data at the AACR
17 Jun 2020 //
BUSINESSWIRE
Meet the protein responsible for nearly $100B in cancer drug deals
17 Aug 2019 //
BIOPHARMADIVE
Clovis Oncology Announces Interim Results from Rubraca® (rucaparib)
02 Apr 2019 //
BUSINESSWIRE
Clovis loses Servier pact, agrees to settle SEC case
02 Aug 2018 //
FIERCE BIOTECH
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.